Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Gabrail Cancer Center | Researchclopedia

Back to institutions

Gabrail Cancer Center

Canton, Ohioother

266

Works

15,030

Citations

71

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Multiple Myeloma Research and Treatments Lung Cancer Treatments and Mutations

Top Researchers

Guillermo Garcia‐Manero The University of Texas MD Anderson Cancer Center

2,926 works89,196 citationsh-index: 149

Recent Research

BXQ-350 efficacy and safety evaluation in first line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in newly diagnosed metastatic colorectal carcinoma.

Tariq Arshad,Michael Gazda,et al.

20260 citations

Cancer Treatment and Pharmacology

Protein Degradation and Inhibitors

Chronic Lymphocytic Leukemia Research

Acute Myeloid Leukemia Research

CAR-T cell therapy research

Colorectal Cancer Treatments and Studies

Immunotherapy and Immune Responses

Nuclear Structure and Function

Lung Cancer Research Studies

Razelle Kurzrock Froedtert Hospital

2,312 works87,178 citationsh-index: 144

James M. Wilson St Bartholomew's Hospital

1,354 works85,503 citationsh-index: 155

Eleftherios P. Mamounas Goethe University Frankfurt

388 works48,449 citationsh-index: 86

Peter J. O’Dwyer Hospital of the University of Pennsylvania

768 works42,104 citationsh-index: 87

Zeev Estrov The University of Texas MD Anderson Cancer Center

1,083 works40,683 citationsh-index: 102

A phase 1b/2 study on the efficacy and safety of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma.

Tariq Arshad,Michael Gazda,et al.

20260 citations

Bxq-350 in combination with FOLFOX7 and bevacizumab: Evaluation of effect on oxaliplatin-induced CIPN—A phase 1b/2 trial to assess the efficacy and safety of BXQ-350, a first-in-class sphingolipid metabolism modulator, in newly diagnosed metastatic colorectal carcinoma.

Tariq Arshad,Michael Gazda,et al.

20260 citations

A phase 1/2 study of revumenib in patients (pts) with advanced colorectal cancer (CRC) and other solid tumors.

Aparna R. Parikh,Kristen Keon Ciombor,et al.

20260 citations

A dose optimization phase 1b/2 study evaluating mipletamig (formerly APVO436), a novel bispecific CD123 x CD3 ADAPTIRÒ molecule in combination therapy for the treatment of frontline acute myeloid leukemia (AML) in patients unfit for intensive chemotherapy

Justin M. Watts,Gautam Borthakur,et al.

20251 citations

SGR-1505, a potent and selective MALT1 inhibitor with preliminary efficacy in BTKi exposed Waldenström macroglobulinemia (WM) and “double-exposed” CLL/SLL

Stephen E. Spurgeon,Vincent Ribrag,et al.

20250 citations